![(11bS)-2,6-双[3,5-双(三氟甲基)苯基]-8,9,10,11,12,13,14,15-八氢-4-羟基-4-氧化物二萘[2-,1-d:1',2'-f][1,3,2]二氧磷杂七环 (11bS)-2,6-Bis[3,5-bis(trifluoromethyl)phenyl]-8,9,10,11,12,13,14,15-octahydro-4-hydroxy-4-oxide-dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepin, 98%, (99% ee)](https://img.nicebiochem.com/20250502/89f20c8981610e19156414693f4e35e9bbcfb53340c3e8864505e2df67fc248b.png)
(11bS)-2,6-双[3,5-双(三氟甲基)苯基]-8,9,10,11,12,13,14,15-八氢-4-羟基-4-氧化物二萘[2-,1-d:1',2'-f][1,3,2]二氧磷杂七环 (11bS)-2,6-Bis[3,5-bis(trifluoromethyl)phenyl]-8,9,10,11,12,13,14,15-octahydro-4-hydroxy-4-oxide-dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepin, 98%, (99% ee)
-
(11bS)-8,9,10,11,12,13,14,15-八氢-4-羟基-2,6-双[3,5-双[3,5-双(三氟甲基)苯基]苯基]-4-氧化物-二萘酚[2,1-d:1',2'-f][1,3,2]二氧磷,98%,(99%ee) (11bS)-8,9,10,11,12,13,14,15-Octahydro-4-hydroxy-2,6-bis[3,5-bis[3,5-bis(trifluoromethyl)phenyl]phenyl]-4-oxide-dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepin, 98%, (99% ee)
ZMR-15-0558 | 100mg
-
(11bR)-8,9,10,11,12,13,14,15-八氢-4-羟基-2,6-双[3,5-双[3,5-双(三氟甲基)苯基]苯基]-4-氧化物-二萘酚[2,1-d:1',2'-f][1,3,2]二氧磷,98% (11bR)-8,9,10,11,12,13,14,15-Octahydro-4-hydroxy-2,6-bis[3,5-bis[3,5-bis(trifluoromethyl)phenyl]phenyl]-4-oxide-dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepin, 98%
ZMR-15-0573 | 25mg
-
(11bS)-2,6-双(3,5-二甲基苯基)-8,9,10,11,12,13,14,15-八氢-4-羟基-4-氧化物-二萘并[2,1-d:1',2'-f][1,3,2]二氧磷杂七环 (11bS)-2,6-Bis(3,5-dimethylphenyl)-8,9,10,11,12,13,14,15-octahydro-4-hydroxy-4-oxide-dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepin, 98%, (99% ee)
ZMR-15-1374 | 100mg
-
(11bS)-8,9,10,11,12,13,14,15-八氢-4-羟基-2,6-双(三苯基)-4-氧化物-二萘并[2,1-d:1',2'-f][1,3,2]二氧磷杂七环 (11bS)-8,9,10,11,12,13,14,15-Octahydro-4-hydroxy-2,6-bis(triphenylsilyl)-4-oxide-dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepin, 98%, (99% ee)
ZMR-15-0821 | 50mg
-
(11bS)-8,9,10,11,12,13,14,15-八氢-4-羟基-2,6-二[4-(三氟甲基)苯基]-4-氧化物-二萘并[2,1-d:1',2'-f][1,3,2]二氧磷杂七环 (11bS)-8,9,10,11,12,13,14,15-Octahydro-4-hydroxy-2,6-bis[4-(trifluoromethyl)phenyl]-4-oxide-dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepin, 98% (99% ee)
ZMR-15-0406 | 50mg
-
(11bR)-2,6-双(3,5-二甲基苯基)-8,9,10,11,12,13,14,15-八氢-4-羟基-4-氧化物-二萘并[2,1-d:1',2'-f][1,3,2]二氧磷杂七环 (11bR)-2,6-Bis(3,5-dimethylphenyl)-8,9,10,11,12,13,14,15-octahydro-4-hydroxy-4-oxide-dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepin, 98%, (99% ee)
ZMR-15-1373 | 100mg
-
(11bS)-2,6-双[4-(2-萘基)苯基]-8,9,10,11,12,13,14,15-八氢-4-羟基-4-氧化物-二萘并[2,11-d:1',2'-f][1,3,2]二氧磷杂七环 (11bS)-2,6-Bis[4-(2-naphthalenyl)phenyl]-8,9,10,11,12,13,14,15-octahydro-4-hydroxy-4-oxide-dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepin, 98% (99% ee)
ZMR-15-0390 | 50mg
中文名称：(11bS)-2,6-双[3,5-双(三氟甲基)苯基]-8,9,10,11,12,13,14,15-八氢-4-羟基-4-氧化物二萘[2-,1-d:1',2'-f][1,3,2]二氧磷杂七环
英文名称：(11bS)-2,6-Bis[3,5-bis(trifluoromethyl)phenyl]-8,9,10,11,12,13,14,15-octahydro-4-hydroxy-4-oxide-dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepin, 98%, (99% ee)
其他规格：25mg；分子式：C36H25F12O4P；分子量：780.5。
您正在浏览的产品：(11bS)-2,6-双[3,5-双(三氟甲基)苯基]-8,9,10,11,12,13,14,15-八氢-4-羟基-4-氧化物二萘[2-,1-d:1',2'-f][1,3,2]二氧磷杂七环
手机版：(11bS)-2,6-双[3,5-双(三氟甲基)苯基]-8,9,10,11,12,13,14,15-八氢-4-羟基-4-氧化物二萘[2-,1-d:1',2'-f][1,3,2]二氧磷杂七环
本公司销售的所有产品仅供实验科研使用，不用于人体及临床诊断。
2. 色谱条件优化：流动相流速1.0 mL/min，柱温30°C，进样量10 μL；
3. 系统适应性测试：理论塔板数≥5000，拖尾因子≤1.2。
以上信息仅供参考，请以相应标准的原文为准！